NO772575L - Fremgangsm}te for fremstilling av farmas¦ytisk aktive preparater - Google Patents

Fremgangsm}te for fremstilling av farmas¦ytisk aktive preparater

Info

Publication number
NO772575L
NO772575L NO772575A NO772575A NO772575L NO 772575 L NO772575 L NO 772575L NO 772575 A NO772575 A NO 772575A NO 772575 A NO772575 A NO 772575A NO 772575 L NO772575 L NO 772575L
Authority
NO
Norway
Prior art keywords
procedures
preparation
pharmaceutical active
active preparations
preparations
Prior art date
Application number
NO772575A
Other languages
English (en)
Other versions
NO149874B (no
NO149874C (no
Inventor
Dragan Hazler
John Arthur Hersey
Jean-Pierre Nougaret
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO772575L publication Critical patent/NO772575L/no
Publication of NO149874B publication Critical patent/NO149874B/no
Publication of NO149874C publication Critical patent/NO149874C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO772575A 1976-07-27 1977-07-19 Fremgangsmaate for fremstilling av et pindololholdig farmasoeytisk produkt NO149874C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH958876 1976-07-27

Publications (3)

Publication Number Publication Date
NO772575L true NO772575L (no) 1978-01-30
NO149874B NO149874B (no) 1984-04-02
NO149874C NO149874C (no) 1984-07-11

Family

ID=4353539

Family Applications (1)

Application Number Title Priority Date Filing Date
NO772575A NO149874C (no) 1976-07-27 1977-07-19 Fremgangsmaate for fremstilling av et pindololholdig farmasoeytisk produkt

Country Status (27)

Country Link
JP (1) JPS5315411A (no)
AR (1) AR216479A1 (no)
AT (1) AT369987B (no)
AU (1) AU515738B2 (no)
BE (1) BE857122A (no)
CA (1) CA1095833A (no)
CY (1) CY1261A (no)
DE (1) DE2732335C2 (no)
DK (1) DK325677A (no)
ES (1) ES461020A1 (no)
FI (1) FI772217A (no)
FR (1) FR2359607A1 (no)
GB (1) GB1589982A (no)
GR (1) GR65014B (no)
HK (1) HK81884A (no)
HU (1) HU178340B (no)
IE (1) IE45534B1 (no)
IL (1) IL52587A (no)
KE (1) KE3441A (no)
MY (1) MY8400057A (no)
NL (1) NL176227C (no)
NO (1) NO149874C (no)
NZ (1) NZ184722A (no)
PT (1) PT66850B (no)
SE (1) SE437469B (no)
SG (1) SG53884G (no)
ZA (1) ZA774536B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH649216A5 (de) * 1979-08-16 1985-05-15 Sandoz Ag Verfahren zur auftragung eines magensaftresistenten filmes auf einen heilmittelkern und feste einheitsdosierungsform mit magensaftresistentem film.
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
JPS6056122B2 (ja) * 1980-05-21 1985-12-09 塩野義製薬株式会社 徐放性製剤
JPS5748908A (en) * 1980-09-08 1982-03-20 Kyorin Pharmaceut Co Ltd Prolonged release type nicomol pharmaceutical
US4795327A (en) * 1984-03-26 1989-01-03 Forest Laboratories, Inc. Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
US4540566A (en) * 1984-04-02 1985-09-10 Forest Laboratories, Inc. Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose
JPS61254522A (ja) * 1985-05-02 1986-11-12 Takada Seiyaku Kk 錠剤組成物
JPS62246512A (ja) * 1986-04-18 1987-10-27 Fujisawa Pharmaceut Co Ltd 反復作用製剤
GB9714675D0 (en) * 1997-07-11 1997-09-17 Smithkline Beecham Plc Novel composition
DE19959419A1 (de) 1999-12-09 2001-06-21 Ratiopharm Gmbh Stabile galenische Zubereitungen umfassend ein Benzimidazol und Verfahren zu ihrer Herstellung
US20030113366A1 (en) * 2001-12-14 2003-06-19 Macgregor Alexander Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3148124A (en) * 1962-06-12 1964-09-08 William E Gaunt Method of preparing sustained release pharmaceutical tablets
CA927282A (en) * 1968-09-03 1973-05-29 S. Banker Gilbert Entrapment compositions and processes
GB1301849A (no) * 1969-12-15 1973-01-04
US3558768A (en) * 1969-12-19 1971-01-26 Sterling Drug Inc Sustained release pharmaceutical compositions

Also Published As

Publication number Publication date
SE437469B (sv) 1985-03-04
FR2359607A1 (fr) 1978-02-24
SE7708265L (sv) 1978-01-28
AT369987B (de) 1983-02-25
JPS5315411A (en) 1978-02-13
AR216479A1 (es) 1979-12-28
IL52587A0 (en) 1977-10-31
NL176227C (nl) 1985-03-18
DK325677A (da) 1978-01-28
JPS5726650B2 (no) 1982-06-05
DK325877A (da) 1978-01-20
PT66850B (fr) 1979-03-13
DE2732335A1 (de) 1978-02-02
GR65014B (en) 1980-06-13
IE45534B1 (en) 1982-09-22
FI772217A (no) 1978-01-28
NL176227B (nl) 1984-10-16
HU178340B (en) 1982-04-28
IE45534L (en) 1978-01-27
ATA541377A (de) 1982-07-15
ZA774536B (en) 1979-02-28
AU2730177A (en) 1979-02-01
PT66850A (fr) 1977-08-01
MY8400057A (en) 1984-12-31
GB1589982A (en) 1981-05-20
CY1261A (en) 1984-11-23
BE857122A (fr) 1978-01-25
KE3441A (en) 1984-09-14
FR2359607B1 (no) 1980-02-22
SG53884G (en) 1985-03-08
DE2732335C2 (de) 1983-01-20
IL52587A (en) 1980-09-16
NO149874B (no) 1984-04-02
AU515738B2 (en) 1981-04-30
NL7708162A (nl) 1978-01-31
NO149874C (no) 1984-07-11
NZ184722A (en) 1980-10-24
HK81884A (en) 1984-11-25
CA1095833A (en) 1981-02-17
ES461020A1 (es) 1979-05-01

Similar Documents

Publication Publication Date Title
NO770465L (no) Fremgangsm}te for fremstilling av fysiologisk aktive karboksyalkylacyl-aminosyrer.
NO147243C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater
NO149586C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive polypeptider
NO149102C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive trans-4-fenyl-1,2,3,4-tetrahydro-1-naftalenamin-derivater
NO773384L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater
NO150360C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacyldipeptider
NO156787C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO147986C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive fenyletylaminer
NO772575L (no) Fremgangsm}te for fremstilling av farmas¦ytisk aktive preparater
NO149428C (no) Fremgangsmaate for fremstilling av fysiologisk aktive prostaglandinderivater.
NO790523L (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive 2-fenyliminoimidazolidiner
NO772329L (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive imidazolinderivater
FI65910B (fi) Foerfarande foer framstaellning av farmaceutiska preparat med laongtidsverkan
NO771884L (no) Fremgangsm}te for fremstilling av terapeutisk aktive polyribonukleotider
NO148488C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acyl-benzimidazol-2-derivater
SE440500B (sv) Forfarande for framstellning av optiskt aktiva antracyklinoner
NO784325L (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive tetracyklononanderivater
NO794318L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive spiro-kinolyl-hydantoin-derivater
NO773344L (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive pyridobenzodiazepinoner
FI792303A (fi) Farmaceutisk komposition foer rektal administration av kefalosporin
NO803115L (no) Fremgangsmaate for fremstilling av stivelselim
NO154131C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO146600C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolderivater
FI792476A (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva tiofenkarboxamidoalkylmerkaptaner
NO154635C (no) Fremgangsmaate for fremstilling av terapeutisk aktive ergotalkaloider.